almagate has been researched along with Epiretinal Membrane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurihara, T; Nagai, N; Okamoto, T; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
2 other study(ies) available for almagate and Epiretinal Membrane
| Article | Year |
|---|---|
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
Topics: Aged; Aptamers, Nucleotide; Basement Membrane; Coloring Agents; Epiretinal Membrane; Fluorescein Angiography; Humans; Indocyanine Green; Intraoperative Period; Male; Retinal Perforations; Vascular Endothelial Growth Factor A; Vitrectomy; Wet Macular Degeneration | 2014 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |